Advantage Partners is a leading provider of services to private equity and similar funds focused on the Japanese and Asian markets. Advantage Partners was founded in 1992 by Taisuke Sasanuma and Richard Folsom and has been providing services to funds since 1997, when the firm established the first buyout fund in Japan. Funds served by Advantage Partners have invested in more than 40 companies representing total invested capital approaching JPY300 billion across a wide range of industries and sectors. Advantage Partners has offices in Tokyo and in Hong Kong.
Affinity Equity Partners is an independently owned private equity fund managers established in March 2004 following the spin-off of the UBS Capital Asia Pacific team, the successful private equity arm of UBS AG in the region. Affinity raised its third external fund of US$3.8 billion in early-2014. Affinity currently advises and manages approximately US$8 billion of funds and assets, making it one of the largest independent financial sponsors in the region. Affinity operates out of 6 offices: Hong Kong, Singapore, Seoul, Sydney, Beijing and Jakarta.
AIF Capital (www.aifcapital.com) is one of Asia’s long-standing independent private equity firms focused on mid-market growth opportunities in emerging Asia. The Firm has an established track record of over two decades in implementing a pan-Asian strategy, with 44 investments across 10 Asian countries. Since our inception in 1994, AIF Capital has received investor commitments of over US$2.0 billion. Our investors include major corporate and government pension and investment funds, insurance companies, financial institutions as well as multilateral agencies and family offices. The firm currently has 18 investment professionals across its offices in Hong Kong, Beijing, New Delhi and Singapore.
Asia Alternatives is a solution platform dedicated to helping institutional investors make investments in private equity across Asia. The firm is currently managing Asia Alternatives Capital Partners, LP ($515 million), Asia Alternatives Capital Partners II, LP ($950 million), Asia Alternatives Capital Partners III, LP ($908 million), Asia Alternatives Capital Partners IV, LP, along with its sleeve fund, AACP IV Ex-Japan Investors, LP (collectively $1 billion) and other funds, all of which are Asia‐focused private equity funds‐of‐funds. The firm has over $6.5 billion in assets under discretionary management. Asia Alternatives invests with top performing private equity fund managers across Asia primarily in Greater China (Mainland China, Taiwan, and Hong Kong), Japan, Korea, South East Asia, India and Australia and are diversified across buyout, growth and expansion, venture capital and special situations funds. The firm currently has over 35 professionals and offices across Hong Kong, Beijing, Shanghai and San Francisco. For more information, go to www.asiaalternatives.com.
Bain Capital, LLC is a global private investment firm that manages several pools of capital, including private equity, venture capital, public equity, credit products and absolute return, with approximately $80 billion in assets under management. Since its inception in 1984, the firm has made over 260 private equity investments worldwide. Bain Capital has a distinctly people-intensive, value-added approach to investing, with a strong emphasis on supporting management teams to drive strategic and operating improvements. Bain Capital Asia, the firm’s Asian private equity affiliate, has been investing with the same philosophy since 2006. Bain Capital private equity investments in Asia have included such leading businesses as ASIMCO, Bellsystem24, China Fire & Security, Denon & Marantz, Domino’s Japan, Feixiang, Genpact, Greatview, GOME, Gymboree China, Hero Investments, Jupiter Shop Channel, Skylark, MYOB and Uniview. Bain Capital has offices in Hong Kong, Shanghai, Tokyo, Mumbai, Melbourne, Boston, New York, Chicago, Palo Alto, London, Munich and Luxembourg.
Capital Today is one of the first independent growth capital funds in China. It currently has USD1.2billion under management. Capital Today's vision is to build business for China.
Capital Today is a strong believer of brand and is dedicated to help Chinese entrepreneurs build Number 1 brand. Capital Today is a strong believer of long term investment. Capital Today is a strong believer of focus and is focused in 3 sectors: Consumer, Retail and Internet. Capital Today made many successful investments including JD.com, Tudou.com, Ganji.com, Dianping.com, Yifeng Pharmacy Chain, Cosmo Lady Underwear Chain, Nuts Snack Food Chain, etc.
Clearwater Capital Partners, LLC (Clearwater) is an investment firm founded in December 2001 to invest in credit and special situations in Asia with assets under management of US$1.5 billion. The Firm's extensive knowledge across multiple sectors and industries in China, India, South Korea, Australia, Southeast Asia and Pan Asia has enabled it to invest and realize over US$4 billion of capital across 350 positions. Clearwater employs a three-pronged investment strategy across direct lending, stressed credit, and distressed and special situation opportunities, using rigorous research and on-the-ground due diligence with downside protection and focus on exits. Clearwater employs 50 professionals across six offices located throughout Asia.
Denning & Company LLC is a FINRA registered global private equity advisory firm headquartered in San Francisco, California. Founded in 2001, Denning & Company, LLC provides consulting, marketing, and fundraising services to established general partners as well as newer teams offering unique investment ideas or solutions to limited partner investors worldwide. With over 70 years of combined industry experience, the Denning and Company team has raised capital in excess of $10 billion for general partners based in the U.S., Japan/Asia, UK/Europe, Russia, and Israel from a limited partner base similarly diversified.
IPV Capital is a China-based early growth venture capital firm that brings together Silicon Valley management expertise and China market knowhow to entrepreneurs with the potential to succeed both in China and globally. With offices in Beijing, Shanghai and Palo Alto, the firm invests in high-growth technology businesses including mobility, enterprise, new materials, and services. Backed by the industry's leading investors, IPV offers consistent financial returns through good corporate governance, disruptive technologies, and a clear competitive advantage. The team’s track record in successful company building and investment in China makes them uniquely qualified to manage the challenges of China’s complex business environment.
For more information, see: www.ipvcap.com.
Established in 2007, Kerogen Capital is an independent private equity fund manager focused on the international oil and gas sector. The founding team originated from J.P. Morgan's energy and natural resources group in Asia and the team includes operational and technical industry specialists. Since inception, Kerogen has raised approximately $1.6 billion in private equity and co-investment funds. Kerogen's investors comprise a range of blue-chip institutions including endowment funds, foundations, pension plans, fund of funds, international corporations and family offices.
MBK Partners is one of the leading independent private equity firms in the
Asia-Pacific region, with over US$8.0 billion in capital under management. With
a dedicated focus on North Asia - Korea, Japan and Greater China (China, Taiwan
and Hong Kong) – MBK Partners’ strategy is to do buyouts or control
acquisitions. Our investment teams are located in Seoul, Tokyo, Shanghai and
Hong Kong and are composed of local professionals with strong local
relationships and market knowledge.
MVision is a leading global independent advisory firm. Founded in 2001, the company’s success in raising capital, advising clients and creating investment opportunities in challenging times as well as fair, has set it apart in the world of Private Equity and Direct investments.
MVision’s continued expansion in Asia, making it one of the region’s largest advisers, is driven by the firm’s ability to identify and attract outstanding clients who are current and future market leaders. MVision’s global team of over 50 professionals deliver top quality bespoke advice, strategic industry insights, and creative solutions to its clients, as well as nurturing close working relationships with local Asian investors, providing them access to the firm’s diversified and high quality client base.
PEP Funds take control positions in a select group of Australian and New Zealand companies with enterprise values in the range A$200M-A$1B. Operating company management are provided with capital and resources as necessary to deliver full potential.
Established in 1998, the firm has made 24 operating company investments, over 70 bolt-ons and joint venture acquisitions at the company level and manages over A$5B of equity funds. Recent investments have spanned industrial, energy, food, consumer products, entertainment/media and the financial services industries; employing over 50,000 people and generating some A$850M in EBITDA.
In terms of liquidity and returns PEP has been fortunate over the last 17 years to be among the best performers in the industry worldwide and recognised with a number of awards, including Australian Private Equity Firm of the Year, and has been noted as most consistent high performing GP in Asia.
Capbridge is the global private capital platform connecting institutional investors to professionally led transactions in emerging growth companies. Investors on the platform can access opportunities in an efficient, tech-enabled environment, and invest directly on a “no-fee, no-carry” basis for enhanced portfolio returns. Capbridge aims to reduce the challenges of sourcing quality deals, due diligence burden and adverse selection. For companies, Capbridge provides enhanced capital access to reach optimal potential and desired exit.
CapBridge is a collaboration between Singapore Exchange (SGX), the premier access point for managing Asian capital and investment exposure, Healthios Capital Markets, a US-based investment bank serving the financing needs of emerging growth companies, and Clearbridge Accelerator, one of Singapore's leading venture capital and incubation firms.
Edelweiss Alternative Asset Advisors (EAAA) is the alternative asset management arm of the Edelweiss Group, one of India’s largest independent financial services groups.
EAAA houses multiple India-focused funds across strategies like collateralized credit, distressed and stressed credit, and real estate. As one of the largest arrangers of private credit for Indian companies (from global and local LPs) EAAA has a unique perspective on the challenges and opportunities in the Indian credit market. Credit is a scalable asset class in India and Edelweiss’ investment strategy provides a good way to play the India growth story in a risk adjusted manner.
Founded in late 2007, FountainVest Partners is one of the largest private equity funds dedicated to China with approximately US$2.6 billion of capital under management and offices in Shanghai, Beijing and Hong Kong. FountainVest partners with emerging leaders with a proven track record in delivering high growth. Combining the firm's international standard of due diligence and investing best practices with local expertise of our investment team, FountainVest takes a long-term and disciplined approach to create value for our domestic partners and our international investors.
Our anchor investors include Canada Pension Plan Investment Board, Ontario Teachers' Pension Plan and Temasek Holdings.
Keytone Ventures is a China-focused venture capital firm investing in transformative ideas for the increasingly interconnected global economy. We look to partner with entrepreneurs breaking ground in emerging industries with innovative technologies and business models.
Founded in 2008, Keytone is led by a team of seasoned investors who were among the first venture capitalists in China. We’ve amassed substantive operational experience and industry knowledge during our many years leading some of China's most successful investments. Our founding team includes the former Founding Managing Partner at KPCB China and former partners at IDG-Accel.
Keytone is dedicated to working with outstanding companies to drive the next wave of innovation in China’s technology transformation. Our portfolio companies have strived to become industry leaders in China or globally, including Garena, China PnR, NanoH2O, Analogix, mCube, Papaya and Centrillion. Keytone targets early-stage and early-growth stage companies and primarily identifies investment opportunities in technology, healthcare, mobile internet and consumer services.
Magic Stone Alternative Investments ("Magic Stone Alternative") is an independent and integrated asset management firm that specializes in alternative investment in China. Magic Stone Alternative is committed to achieving capital appreciation for investors through making direct investment as well as investing in Private Equity funds.
Magic Stone Alternative's value proposition reflects in its investment excellence, deep-local expertise and ability for full-service solution. Magic Stone Alternative's investment excellence builds upon the team's proven investment record, local expertise and depth of industry connections. The team has developed unparalleled market access, proprietary research system and institutional-quality due diligence process that in comply with global good practices.
Magic Stone Alternative is managing total assets of around USD1 billion. Since establishment in 2011, Magic Stone Alternative has been focused on investment in internet and healthcare industry. Up to now, Magic Stone Alternative has made investments in about 40 private companies and 10 emerging VC/PE funds. Portfolio companies include: BGI, Jimubox, Zhaogang.com., Xiao Ka Technology, Tujia.com etc.
Morgan Stanley Private Equity Asia (“MSPEA”) is one of the leading private equity investors in Asia Pacific, having invested in the region for over 22 years. The team has invested approximately $3.2 billion in Asia, primarily in highly structured minority investments and control buyouts in profitable, growth-oriented companies at attractive valuations with a significant majority of the investments sourced on a proprietary basis.
MSPEA has an experienced investment team led by senior professionals with extensive networks, in-depth market knowledge and the ability to apply international investment principals within each local context. MSPEA has offices located in Hong Kong, Beijing, Shanghai, Seoul, Tokyo, Mumbai and New York.
Proskauer is a leading international law firm with more than 700 highly skilled lawyers active in virtually every major market across the globe. Headquartered in New York since 1875, we also have offices in Beijing, Boca Raton, Boston, Chicago, Hong Kong, London, Los Angeles, New Orleans, Newark, Paris, São Paulo and Washington, D.C.
The firm has experience in all areas of practice important to businesses and individuals. Our Private Investment Funds Group is a dynamic interdisciplinary team of lawyers offering a complete package of services to private investment funds and institutional investors globally. We advise sponsors and managers in structuring funds, institutional investors in their alternative investment programs and buyers, sellers and intermediaries in all types of secondaries transactions.
TOKIO MARINE CAPITAL (TMCap) is a private equity investment firm that manages investments in small to mid-cap private companies in Japan. Though founded in 1991 and developed as venture capital arm of Tokio Marine group, TMCap shifted its investment style to buyout fund management in 1998, when the first fund was established. The firm has invested to date nearly 20 buyout investments through 4 funds and has achieved successful track records with no single loss. Emphasis is put on moderate and sustainable value creation through strong support of management team. TMCap invests wide range of industries, including healthcare (pharmaceutical), retail, industrial, and business services.
Distinguished by its affiliation with the nation’s leading insurance company with more than 130 year-old reputation, TMCap is uniquely located to take advantage of its accumulated goodwill that helps to open doors to companies, namely family owners across the country, while having established quite independent team’s decision making and monitoring system.
TMCap is based in Tokyo and currently has 9 investment professionals with a wide variety of business experience and expertise.
Southern Capital is a leading private equity firm that focuses on control investments in middle market businesses in Southeast Asia. The firm practises an active post investment value creation strategy and has a successful track record of acquiring and growing middle market businesses with enterprise values of between US$20 million to US$200 million.
Operating from offices in Singapore and Kuala Lumpur, Southern Capital seeks to make proprietary investments in businesses that have proven track records, healthy cash flows and strong management teams. The firm has considerable investment and operational expertise in certain industries such as healthcare, education, value-added manufacturing, business process outsourcing, consumer products and services and selected infrastructure.
eVestment provides a flexible suite of easy-to-use, cloud-based solutions to help the institutional investing community identify and capitalize on global investment trends, better select and monitor investment managers and more successfully enable asset managers to market their funds worldwide. With the largest, most comprehensive global database of traditional and alternative strategies, delivered through leading-edge technology and backed by fantastic client service, eVestment helps its clients be more strategic, efficient and informed. For more information, visit www.evestment.com
ICBI is part of the Knowledge & Networking Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.